Four-Month Pilot Aims to Address Illegal Online Opioid Sales
Written by: Matthew Rubin and Libby Baney, Faegre Drinker Consulting On June 8, 2020, Food and Drug Administration (FDA) and Department of Commerce’s National Telecommunications and Information Administration (NTIA) formally announced the formation of a 120-day pilot program targeting the illegal advertisement and sale of prescription opioids and illicit narcotics online. This announcement builds upon […]
Read More ›Global COVID-19 Threats Persist as Online Fraud and Theft Continue
Written by: Matthew Rubin, Faegre Drinker Consulting Now more than two months into the United States’ public health emergency for the coronavirus disease 2019 (COVID-19) pandemic, consumer behavior and related commerce have changed drastically. Stay-in-place orders, social distancing practices, and self-imposed quarantines have left hundreds of millions of Americans – and billions more globally – […]
Read More ›Illegal Online Pharmacies Exploit Vulnerable Consumers During the COVID-19 Pandemic
The National Association of Boards of Pharmacy® (NABP®) released the May 2020 Rogue Rx Activity Report, Rogue Online Pharmacies in the Time of Pandemic: Capitalizing on Misinformation and Fear. The report highlights how illegal online pharmacies use coronavirus disease 2019 (COVID-19) to expand operations and prey on consumer fears. NABP has identified dozens of rogue online pharmacies […]
Read More ›Lemrey “Al” Carter, MS, PharmD, RPh, Assumes Position of NABP Executive Director/Secretary
The National Association of Boards of Pharmacy® (NABP®) Executive Committee is pleased to announce that Lemrey “Al” Carter, MS, PharmD, RPh, assumed the position of executive director/secretary at the close of the Association’s 116th Annual Meeting, which was held virtually on May 14, 2020. He succeeds Carmen A. Catizone, MS, RPh, DPh, the fourth NABP […]
Read More ›Amid COVID-19, Internet Intermediaries Can – and Should – Combat Fraud and Harms
Written by: Libby Baney and Matthew Rubin, Faegre Drinker Consulting Consistent with nearly every public health crisis in recent times, illegal actors have leveraged consumer fear and confusion to make short-term profits without significant risk of enforcement. It is happening again now. Since World Health Organization declared the coronavirus disease 2019 (COVID-19) a pandemic on […]
Read More ›Counterfeiters Pounce on Coronavirus Fears, Federal Regulators Respond
Written by: Libby Baney, Faegre Drinker LLP and Matthew Rubin, Faegre Drinker Consulting Amid what the World Health Organization now considers a worldwide pandemic, coronavirus (also known as COVID-19) has been the source of deep concern for individuals and communities across the globe. We hope all reading this have remained safe and healthy throughout the […]
Read More ›NABP Supports Boards of Pharmacy to Expedite Emergency Licensure for Pharmacists and Pharmacy Technicians
The National Association of Boards of Pharmacy® (NABP®) is assisting its member boards of pharmacy in expediting emergency and temporary licensure requests for licensed pharmacists and pharmacy technicians through its new program, NABP Passport. Developed in response to coronavirus disease 2019 (COVID-19), NABP Passport facilitates temporary authorization for pharmacists and pharmacy technicians to practice in […]
Read More ›Joint Statement of FSMB and NABP on Inappropriate Prescribing and Dispensing of Medications During the COVID-19 Pandemic
Recent news reports indicate that in response to the coronavirus pandemic, some physicians are inappropriately prescribing medications (including chloroquine, hydroxychloroquine, and azithromycin) to prevent or treat COVID-19 for themselves or their family members, and that some pharmacies and hospitals may be stockpiling these medications in anticipation of future demand. In the midst of a national […]
Read More ›FDA Thwarts 500 Illicit Drug Shipments in Partnership With Indian Officials
By: Matthew Rubin, Faegre Drinker Consulting Food and Drug Administration (FDA) has announced the successful execution of a collaborative enforcement effort with the government of India, the first bilateral operation between the two countries. Between January 28-30, 2020, enforcement officials identified significant threats to United States patients with the arrival of potentially counterfeit, substandard, or […]
Read More ›HHS and FDA Open Notice and Comment Period for Draft Importation Rule
By: Libby Baney and Matthew Rubin, Faegre Baker Daniels Last month, we chronicled all that has occurred the past year related to prescription drug importation and implications for the cost of medicines and potential impacts on patient safety. In 2020, the Trump Administration is pushing forward on its promises to take such actions. On Monday, […]
Read More ›